<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03484767</url>
  </required_header>
  <id_info>
    <org_study_id>mRNA-3704-P001</org_study_id>
    <nct_id>NCT03484767</nct_id>
  </id_info>
  <brief_title>&quot;The MaP Study&quot;: Mapping the Patient Journey in MMA and PA</brief_title>
  <official_title>A Longitudinal, Exploratory, Natural History Study to Further Characterize and Describe the Signs and Symptoms of Patients With Organic Acidemias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ModernaTX, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ModernaTX, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Longitudinal, exploratory, natural history study of patients with MMA due to mut deficiency&#xD;
      and PA to characterize the changes in blood disease biomarkers over time and the frequency&#xD;
      and severity of clinical events related to their disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 20, 2018</start_date>
  <completion_date type="Actual">May 29, 2021</completion_date>
  <primary_completion_date type="Actual">May 29, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in plasma methylmalonic acid levels (MMA only)</measure>
    <time_frame>Baseline through 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of disease related clinical events in enrolled participants (mut0 and mut- MMA patients)</measure>
    <time_frame>Baseline through 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in plasma 2-MC levels (PA only)</measure>
    <time_frame>Baseline through 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in plasma 3-HP levels (PA only)</measure>
    <time_frame>Baseline through 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of disease related clinical events in enrolled participants (PA patients)</measure>
    <time_frame>Baseline through 12 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">97</enrollment>
  <condition>Methylmalonic Acidemia</condition>
  <condition>Propionic Acidemia</condition>
  <arm_group>
    <arm_group_label>Methylmalonic Acidemia Participants</arm_group_label>
    <description>Individuals with isolated MMA (mut0 and mut-)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propionic Acidemia Participants</arm_group_label>
    <description>Individuals with isolated PA</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals of any age with confirmed diagnosis of isolated MMA due to MUT deficiency (mut0&#xD;
        or mut-) or isolated PA&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        MMA Only • Patient has a confirmed diagnosis of isolated MMA due to MUT deficiency (mut0 or&#xD;
        mut-) based on the following criteria:&#xD;
&#xD;
          -  Elevated plasma/serum/DBS or urine methylmalonic acid levels&#xD;
&#xD;
          -  Presence of normal serum/plasma vitamin B12 and plasma homocysteine levels&#xD;
&#xD;
          -  Confirmed by molecular genetic testing. Genetic testing can be performed after the&#xD;
             administration of informed consent if not available, however, molecular genetic&#xD;
             results must be confirmed before the second study visit&#xD;
&#xD;
        PA Only&#xD;
&#xD;
        • Patient has a confirmed diagnosis of isolated PA based on the following criteria:&#xD;
&#xD;
          -  Elevated plasma/DBS/urine 2-MC and/or 3-HP&#xD;
&#xD;
          -  Elevated plasma/serum/DBS propionylcarnitine (C3)&#xD;
&#xD;
          -  Confirmed by genetic testing for mutations of the PCCA or PCCB genes. Genetic testing&#xD;
             can be performed after the administration of informed consent if not available,&#xD;
             however, molecular genetic results must be confirmed before the second study visit&#xD;
&#xD;
        Both MMA and PA&#xD;
&#xD;
          -  Patient (and/or legally authorized representative as applicable to local regulations)&#xD;
             is willing and able to comply with study-related assessments and activities&#xD;
&#xD;
          -  Patient or legally authorized representative is willing and able to provide informed&#xD;
             consent and/or assent as mandated by local regulation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Estimated GFR &lt;30 mL/min/1.73m2 based on age appropriate equations or patients who&#xD;
             undergo chronic dialysis&#xD;
&#xD;
          -  The patient is pregnant or lactating at the time of screening. (Note: Patients who&#xD;
             become pregnant during the study may remain in the study) MMA Only&#xD;
&#xD;
          -  Patients diagnosed with isolated MMA cblA, cblB, or cblD enzymatic subtypes or&#xD;
             methylmalonyl-CoA epimerase deficiency or combined MMA with homocystinuria PA Only&#xD;
&#xD;
          -  Patient has a confirmed diagnosis of multiple carboxylase deficiency&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stanford Health Services</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory Univeristy</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Timone</name>
      <address>
        <city>Marseille cedex 15</city>
        <state>Bouches-du-Rhône</state>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker - Enfants Malades</name>
      <address>
        <city>Paris cedex 15</city>
        <state>Paris</state>
        <zip>75743</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Cruces</name>
      <address>
        <city>Barakaldo</city>
        <state>Vizcaya</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Ormond Street Hospital</name>
      <address>
        <city>Bloomsbury</city>
        <state>Greater London</state>
        <zip>WC1N 3JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Children's Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B4 6NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manchester University Hospitals</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Italy</country>
  </removed_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 13, 2018</study_first_submitted>
  <study_first_submitted_qc>March 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2018</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>methylmalonic acidemia</keyword>
  <keyword>MMA</keyword>
  <keyword>organic acidemia</keyword>
  <keyword>mut deficiency</keyword>
  <keyword>inborn errors of metabolism</keyword>
  <keyword>mut0</keyword>
  <keyword>mut-</keyword>
  <keyword>PA</keyword>
  <keyword>PCCA</keyword>
  <keyword>PCCB</keyword>
  <keyword>propionic acidemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propionic Acidemia</mesh_term>
    <mesh_term>Acidosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

